Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis
DM Cholon, NL Quinney, ML Fulcher… - Science translational …, 2014 - science.org
Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator
(CFTR). Newly developed “correctors” such as lumacaftor (VX-809) that improve CFTR …
(CFTR). Newly developed “correctors” such as lumacaftor (VX-809) that improve CFTR …
Cystic fibrosis: Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis
DM Cholon, NL Quinney, ML Fulcher… - Science Translational …, 2014 - pure.psu.edu
Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator
(CFTR). Newly developed" correctors" such as lumacaftor (VX-809) that improve CFTR …
(CFTR). Newly developed" correctors" such as lumacaftor (VX-809) that improve CFTR …
[引用][C] Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis
DM Cholon, NL Quinney, ML Fulcher… - Science Translational …, 2014 - cir.nii.ac.jp
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[PDF][PDF] Potentiator Ivacaftor Abrogates Pharmacological Correction of ΔF508 CFTR in Cystic Fibrosis
DM Cholon, NL Quinney, ML Fulcher, CRE Jr, J Das… - researchgate.net
Cystic Fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator
(CFTR). Newly developed “correctors” such as lumacaftor (VX-809) that improve CFTR …
(CFTR). Newly developed “correctors” such as lumacaftor (VX-809) that improve CFTR …
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis
DM Cholon, NL Quinney, ML Fulcher… - Science …, 2014 - pubmed.ncbi.nlm.nih.gov
Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator
(CFTR). Newly developed" correctors" such as lumacaftor (VX-809) that improve CFTR …
(CFTR). Newly developed" correctors" such as lumacaftor (VX-809) that improve CFTR …
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis.
DM Cholon, NL Quinney, ML Fulcher… - Science Translational …, 2014 - europepmc.org
Cystic Fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator
(CFTR). Newly developed “correctors” such as lumacaftor (VX-809) that improve CFTR …
(CFTR). Newly developed “correctors” such as lumacaftor (VX-809) that improve CFTR …
Potentiator ivacaftor abrogates pharmacological correction of F508 CFTR in cystic fibrosis
DM Cholon, NL Quinney, ML Fulcher… - Science Translational …, 2014 - cdr.lib.unc.edu
Cystic Fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator
(CFTR). Newly developed “correctors” such as lumacaftor (VX-809) that improve CFTR …
(CFTR). Newly developed “correctors” such as lumacaftor (VX-809) that improve CFTR …
[HTML][HTML] Potentiator Ivacaftor Abrogates Pharmacological Correction of ΔF508 CFTR in Cystic Fibrosis
DM Cholon, NL Quinney, ML Fulcher… - Science translational …, 2014 - ncbi.nlm.nih.gov
Cystic Fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator
(CFTR). Newly developed “correctors” such as lumacaftor (VX-809) that improve CFTR …
(CFTR). Newly developed “correctors” such as lumacaftor (VX-809) that improve CFTR …
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis.
DM Cholon, NL Quinney, ML Fulcher… - Science Translational …, 2014 - europepmc.org
Cystic Fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator
(CFTR). Newly developed “correctors” such as lumacaftor (VX-809) that improve CFTR …
(CFTR). Newly developed “correctors” such as lumacaftor (VX-809) that improve CFTR …